The portfolio comprises healthcare providers, medical product suppliers, and other service providers in the healthcare market. The company’s lower mid-market buy-out fund invests in profitable European healthcare services companies focusing on the Netherlands, Belgium, and Germany. Gilde Healthcare is a healthcare investor managing two business lines – a lower mid-market buy-out fund and a venture & growth capital fund. The VC’s initial seed investments can be up to €2M, with around €5M to €15M per company over the long haul. The company manages around €140M of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept come together.īGV uses its experience to guide progress into clinical trials, resulting in successful drug development and value realisation for its investors. The Dutch VC has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. BGV (BioGeneration Ventures)īased out of Naarden, BioGeneration Ventures (BGV) is a venture capital company that focuses on early-stage European biotech, medtech, and diagnostics companies. Some of its investments include GitLab, Remote, ChannelEngine, Silverflow, and Castor. The VC raised a €500M fund in 2017 and a €50M top-up in 2021.įrom the early stages of a technology or life science venture, INKEF Capital supports entrepreneurs in building their ideas into successful international businesses. The company writes cheques between €500k and €15M, with significant reservations to follow-on investments. Even though Inkef covers multiple investment stages, it focuses mainly on series A investments. The firm believes in long-term investment with the ability to support companies through several funding rounds up to IPO. “Having such advisors to offer learnings and first-hand insights not only helps founders rapidly execute but provides them with the right strategy to accelerate growth and create category leading brands.Inkef is a venture capital firm based in Amsterdam that backs early-stage European companies. “It was important to me to create a community of seasoned founders who could offer support and advice to entrepreneurs throughout their journey,” Kurt Seidensticker said via email. If early-stage founders can get that kind of deep network early on, it could really help, Kelly added.Īnd while some venture capital firms merely inject funding, The Family Fund’s focus is more on mentorship and extending its network of partners and vendors, or whatever else can help with a company’s operations, marketing and logistics. In fact, they helped him see when he needed to pivot his business, he said. He recalled meeting people who helped shape the strategy of Caroo, not just those who invested, but who were successful founders and operators first. Kelly told TechCrunch that The Family Fund’s “secret sauce” is that they are all operators and therefore are intimately familiar with the startup journey and what it takes to develop a successful company. We saw another consumer brand founder do this recently, too: Daniel Lubetzky, founder of Kind Snacks, plans to deploy $350 million into consumer brands through his new his VC firm, Camino Partners. With the new venture fund, they will back and mentor up-and-coming founders leading consumer and consumer-tech brands. General partners Kurt Seidensticker, founder of Vital Proteins Sean Kelly, founder of SnackNation and Caroo and Josh Wand, founder of Forcebrands, have already amassed a community of over 50 founders and CEOs, including Amanda Baldwin at Supergoop, Tyler Ricks at SuperCoffee, Jake Kassan at MVMT and Jordan Bass at HOP WTR. The Family Fund & Founder Community, which goes by F3C, announced $25 million in new capital commitments and its focus on becoming the largest community of founders that co-invest in the late-seed and Series A stages of consumer brands.
0 Comments
Leave a Reply. |